The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Viral hepatitis and liver cancer
Open accessAbstract
Hepatitis B and C viruses are a global health problem causing acute and chronic infections that can lead to liver cirrhosis and hepatocellular carcinoma (HCC). These infections are the leading cause for HCC worldwide and are associated with significant mortality, accounting for more than 1.3 million deaths per year. Owing to its high incidence and resistance to treatment, liver cancer is the second leading cause of cancer-related death worldwide, with HCC representing approximately 90% of all primary liver cancer cases. The majority of viral-associated HCC cases develop in subjects with liver cirrhosis; however, hepatitis B virus infection can promote HCC development without prior end-stage liver disease. Thus, understanding the role of hepatitis B and C viral infections in HCC development is essential for the future design of treatments and therapies for this cancer. In this review, we summarize the current knowledge on hepatitis B and C virus hepatocarcinogenesis and highlight direct and indirect risk factors. This article is part of the themed issue ‘Human oncogenic viruses’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nasimuzzaman, M., Waris, G., Mikolon, D., Stupack, D. G., & Siddiqui, A. (2007) · Journal of Virology · doi:10.1128/jvi.00763-07 · Cited by 139
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Trépo, C., Chan, H. L. Y., & Lok, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60220-8 · Cited by 1,623
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M., & Weinman, S. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.30983 · Cited by 926
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 899
Molecular biology of hepatitis B virus infection
Seeger, C., & Mason, W. S. (2015) · Virology · doi:10.1016/j.virol.2015.02.031 · Cited by 866
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
Gong, G., Waris, G., Tanveer, R., & Siddiqui, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171311298 · Cited by 584
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Pan, C. Q., Duan, Z., Dai, E., Zhang, S., Han, G., Wang, Y., Zhang, H., Zou, H., Zhu, B., Zhao, W., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508660 · Cited by 573
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Decorsière, A., Mueller, H., van Breugel, P. C., Abdul, F., Gerossier, L., Beran, R. K., Livingston, C. M., Niu, C., Fletcher, S. P., Hantz, O., et al. (2016) · Nature · doi:10.1038/nature17170 · Cited by 551
Nahon, P., Bourcier, V., Layese, R., Audureau, E., Cagnot, C., Marcellin, P., Guyader, D., Fontaine, H., Larrey, D., De Lédinghen, V., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.009 · Cited by 538
Bartsch, H., & Nair, J. (2006) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-006-0073-1 · Cited by 516
Fattovich, G., Giustina, G., Christensen, E., Pantalena, M., Zagni, I., Realdi, G., Schalm, S. W., & (Eurohep), T. E. C. A. O. V. H. (2000) · Gut · doi:10.1136/gut.46.3.420 · Cited by 515
Moriya, K., Nakagawa, K., Santa, T., Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Miyazawa, T., Ishibashi, K., Horie, T., et al. (2001) · PubMed · Cited by 515
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Belloni, L., Pollicino, T., De Nicola, F., Guerrieri, F., Raffa, G., Fanciulli, M., Raimondo, G., & Levrero, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908365106 · Cited by 498
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection
Lucifora, J., Arzberger, S., Durantel, D., Belloni, L., Strubin, M., Levrero, M., Zoulim, F., Hantz, O., & Protzer, U. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.015 · Cited by 481
Self-citationPapatheodoridis, G. V., Lampertico, P., Manolakopoulos, S., & Lok, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.035 · Cited by 459
Mason, W. S., Gill, U. S., Litwin, S., Zhou, Y., Peri, S., Pop, O., Hong, M. L. W., Naik, S., Quaglia, A., Bertoletti, A., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.012 · Cited by 449
Korenaga, M., Wang, T., Li, Y., Showalter, L. A., Chan, T., Sun, J., & Weinman, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506412200 · Cited by 428
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.045 · Cited by 419
El‐Serag, H. B., Kanwal, F., Richardson, P., & Kramer, J. (2016) · Hepatology · doi:10.1002/hep.28535 · Cited by 411
Cheung, M. C. M., Walker, A. J., Hudson, B. E., Verma, S., McLauchlan, J., Mutimer, D. J., Brown, A., Gelson, W. T. H., MacDonald, D. C., Agarwal, K., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.019 · Cited by 408
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
Llovet, J. M., & Hernandez-Gea, V. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0547 · Cited by 397
Calcium Signaling by HBx Protein in Hepatitis B Virus DNA Replication
Bouchard, M. J., Wang, L.-H., & Schneider, R. J. (2001) · Science · doi:10.1126/science.294.5550.2376 · Cited by 385
Kumar, V., Kato, N., Urabe, Y., Takahashi, A., Muroyama, R., Hosono, N., Otsuka, M., Tateishi, R., Omata, M., Nakagawa, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.809 · Cited by 377
Immune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
Nault, J. C., Calderaro, J., Di Tommaso, L., Balabaud, C., Zafrani, E. S., Bioulac‐Sage, P., Roncalli, M., & Zucman‐Rossi, J. (2014) · Hepatology · doi:10.1002/hep.27372 · Cited by 354
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B # †
Chen, C.-J., Yang, H.-I., & Iloeje, U. H. (2009) · Hepatology · doi:10.1002/hep.22884 · Cited by 346
Murakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Bréchot, C., & Paterlini-Bréchot, P. (2005) · Gut · doi:10.1136/gut.2004.054452 · Cited by 331
Immunosurveillance of the Liver by Intravascular Effector CD8 + T Cells
Guidotti, L. G., Inverso, D., Sironi, L., Di Lucia, P., Fioravanti, J., Ganzer, L., Fiocchi, A., Vacca, M., Aiolfi, R., Sammicheli, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.005 · Cited by 323 · cited 2×
“B 3720160274 2 also to a high number of perinatal infections in endemic areas [1,3].”
BackgroundSelf-citationKanwal, F., Kramer, J. R., Ilyas, J., Duan, Z., & El-Serag, H. B. (2014) · Hepatology · doi:10.1002/hep.27095 · Cited by 322
Medical therapies for hepatocellular carcinoma: a critical view of the evidence
Villanueva, A., Hernandez-Gea, V., & Llovet, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.199 · Cited by 314
Identification of driver genes in hepatocellular carcinoma by exome sequencing
Cleary, S. P., Jeck, W. R., Zhao, X., Chen, K., Selitsky, S. R., Savich, G. L., Tan, T.-X., Wu, M. C., Getz, G., Lawrence, M. S., et al. (2013) · Hepatology · doi:10.1002/hep.26540 · Cited by 302
Natural history of chronic hepatitis B REVEALed
Chen, C., & Yang, H. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06695.x · Cited by 275
van der Meer, A. J., Feld, J. J., Hofer, H., Almasio, P. L., Calvaruso, V., Fernández-Rodríguez, C. M., Aleman, S., Ganne-Carrié, N., D’Ambrosio, R., Pol, S., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.017 · Cited by 274
Viral-Human Chimeric Transcript Predisposes Risk to Liver Cancer Development and Progression
Lau, C.-C., Sun, T., Ching, A. K. K., He, M., Li, J.-W., Wong, A. M., Co, N. N., Chan, A. W. H., Li, P.-S., Lung, R. W. M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.030 · Cited by 270
Histone degradation in response to DNA damage enhances chromatin dynamics and recombination rates
Hauer, M. H., Seeber, A., Singh, V., Thierry, R., Sack, R., Amitai, A., Kryzhanovska, M., Eglinger, J., Holcman, D., Owen-Hughes, T., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3347 · Cited by 255
Tropberger, P., Mercier, A., Robinson, M., Zhong, W., Ganem, D. E., & Holdorf, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518090112 · Cited by 246
p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines
Hsu, I. C., Tokiwa, T., Bennett, W., Metcalf, R. A., Welsh, J. A., Sun, T., & Harris, C. C. (1993) · Carcinogenesis · doi:10.1093/carcin/14.5.987 · Cited by 241
Krebs, K., Böttinger, N., Huang, L., Chmielewski, M., Arzberger, S., Gasteiger, G., Jäger, C., Schmitt, E., Bohne, F., Aichler, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.047 · Cited by 227
Self-citationLi, T., Robert, E. I., van Breugel, P. C., Strubin, M., & Zheng, N. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1719 · Cited by 224
Raimondi, S., Bruno, S., Mondelli, M. U., & Maisonneuve, P. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.019 · Cited by 224
MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
Hayes, C., & Chayama, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030280 · Cited by 223
Rivière, L., Gerossier, L., Ducroux, A., Dion, S., Deng, Q., Michel, M.-L., Buendia, M.-A., Hantz, O., & Neuveut, C. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.023 · Cited by 221
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer
McGivern, D. R., & Lemon, S. M. (2011) · Oncogene · doi:10.1038/onc.2010.594 · Cited by 219
Nakagawa, S., Wei, L., Song, W. M., Higashi, T., Ghoshal, S., Kim, R. S., Bian, C. B., Yamada, S., Sun, X., Venkatesh, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.004 · Cited by 205
Zhang, H., Pan, C. Q., Pang, Q., Tian, R., Yan, M., & Liu, X. (2014) · Hepatology · doi:10.1002/hep.27034 · Cited by 199
Attacking hepatitis B virus cccDNA – The holy grail to hepatitis B cure
Lucifora, J., & Protzer, U. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.009 · Cited by 196
Self-citationSpontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
Liu, J., Yang, H.-I., Lee, M.-H., Lu, S.-N., Jen, C.-L., Batrla-Utermann, R., Wang, L.-Y., You, S.-L., Hsiao, C. K., Chen, P.-J., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305785 · Cited by 195
del Canho, R., Grosheide, P. M., Mazel, J. A., Heijtink, R. A., Hop, W. C. J., Gerards, L. J., de Gast, G. C., Fetter, W. P. F., Zwijneberg, J., & Schalm, S. W. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00080-7 · Cited by 190
Leung, N., Peng, C., Hann, H., Sollano, J., Lao‐Tan, J., Hsu, C., Lesmana, L., Yuen, M., Jeffers, L., Sherman, M., et al. (2009) · Hepatology · doi:10.1002/hep.22658 · Cited by 182
The Autotaxin–LPA Axis Emerges as a Novel Regulator of Lymphocyte Homing and Inflammation
Knowlden, S., & Georas, S. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302831 · Cited by 177
Miki, D., Ochi, H., Hayes, C. N., Abe, H., Yoshima, T., Aikata, H., Ikeda, K., Kumada, H., Toyota, J., Morizono, T., et al. (2011) · Nature Genetics · doi:10.1038/ng.876 · Cited by 177
Hepatitis C Virus Core Protein Promotes Immortalization of Primary Human Hepatocytes
Ray, R. B., Meyer, K., & Ray, R. (2000) · Virology · doi:10.1006/viro.2000.0295 · Cited by 162
Munakata, T., Nakamura, M., Liang, Y., Li, K., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505605102 · Cited by 159
Chayanupatkul, M., Omino, R., Mittal, S., Kramer, J. R., Richardson, P. A., Thrift, A. P., El‐Serag, H. B., & Kanwal, F. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.013 · Cited by 156
Migita, K., Miyazoe, S., Maeda, Y., Daikoku, M., Abiru, S., Ueki, T., Yano, K., Nagaoka, S., Matsumoto, T., Nakao, K., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.026 · Cited by 154
Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein
Munakata, T., Liang, Y., Kim, S., McGivern, D. R., Huibregtse, J. M., Nomoto, A., & Lemon, S. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030139 · Cited by 152
Lineage fate of ductular reactions in liver injury and carcinogenesis
Jörs, S., Jeliazkova, P., Ringelhan, M., Thalhammer, J., Dürl, S., Ferrer, J., Sander, M., Heikenwalder, M., Schmid, R. M., Siveke, J. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78585 · Cited by 149
Marco, V. D., Calvaruso, V., Ferraro, D., Bavetta, M. G., Cabibbo, G., Conte, E., Cammà, C., Grimaudo, S., Pipitone, R. M., Simone, F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.036 · Cited by 147
Benhenda, S., Ducroux, A., Rivière, L., Sobhian, B., Ward, M. D., Dion, S., Hantz, O., Protzer, U., Michel, M., Benkirane, M., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02574-12 · Cited by 133
Self-citationYoon, Y. J., Chang, H., Ahn, S. H., Kim, J. K., Park, Y. K., Kang, D. R., Park, J. Y., Myoung, S.-M., Kim, D. Y., Chon, C. Y., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn090 · Cited by 130
Unique Genomic Profile of Fibrolamellar Hepatocellular Carcinoma
Cornellà, H., Alsinet, C., Sayols, S., Zhang, Z., Hao, K., Cabellos, L., Hoshida, Y., Villanueva, A., Thung, S. N., Ward, S. C., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.028 · Cited by 128
Ringelhan, M., O’Connor, T., Protzer, U., & Heikenwälder, M. F. (2014) · The Journal of Pathology · doi:10.1002/path.4434 · Cited by 127
Self-citationMiyamoto, H., Moriishi, K., Moriya, K., Murata, S., Tanaka, K., Suzuki, T., Miyamura, T., Koike, K., & Matsuura, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01683-06 · Cited by 127
Wang, B., Huang, G., Wang, D., Li, A., Xu, Z., Dong, R., Zhang, D., & Zhou, W. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.026 · Cited by 117
Qi, P., Dou, T., Li, G., Zhou, F., Gu, X., Wang, H., & Gao, C. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.017 · Cited by 117
Ferri, C., Ramos‐Casals, M., Zignego, A. L., Arcaini, L., Roccatello, D., Antonelli, A., Saadoun, D., Desbois, A. C., Sebastiani, M., Casato, M., et al. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.006 · Cited by 116
Hepatitis Virus Infection Affects DNA Methylation in Mice With Humanized Livers
Okamoto, Y., Shinjo, K., Shimizu, Y., Sano, T., Yamao, K., Gao, W., Fujii, M., Osada, H., Sekido, Y., Murakami, S., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.056 · Cited by 113
Reversal of Hepatocyte Senescence After Continuous In Vivo Cell Proliferation
Wang, M., Chen, F., Li, J., Liu, C.-C., Zhang, H., Xia, Y., Yu, B., You, P., Xiang, D., Lu, L., et al. (2014) · Hepatology · doi:10.1002/hep.27094 · Cited by 110
Menolfi, D., Delamarre, A., Lengronne, A., Pasero, P., & Branzei, D. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.023 · Cited by 110
Machida, K., McNamara, G. T., Cheng, K. T.-H., Huang, J. Y., Wang, C., Comai, L., Ou, J. J., & Lai, M. M. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000618 · Cited by 107
TERT promoter mutations in primary liver tumors
Nault, J., & Zucman‐Rossi, J. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.07.006 · Cited by 107
Hepatocellular CarcinomaPreprint
Buendia, M., & Neuveut, C. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021444 · Cited by 105
Bandiera, S., Pernot, S., Saghire, H. E., Durand, S., Thumann, C., Crouchet, É., Ye, T., Fofana, I., Oudot, M. A., Barths, J., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00619-16 · Cited by 104
Kofahi, H. M., Taylor, N., Hirasawa, K., Grant, M. D., & Russell, R. S. (2016) · Scientific Reports · doi:10.1038/srep37433 · Cited by 103
Lai, C.-K., Jeng, K.-S., Machida, K., Cheng, Y., & Lai, M. M. C. (2007) · Virology · doi:10.1016/j.virol.2007.08.037 · Cited by 98
Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma
Yuan, K., Lian, Z., Sun, B. S., Clayton, M. M., Ng, I. O., & Feitelson, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035331 · Cited by 96
Ganne‐Carrié, N., Layese, R., Bourcier, V., Cagnot, C., Marcellin, P., Guyader, D., Pol, S., Larrey, D. G., de Lédinghen, V., Ouzan, D., et al. (2016) · Hepatology · doi:10.1002/hep.28702 · Cited by 93
Bohne, F., Londoño, M., Benítez, C., Miquel, R., Martínez‐Llordella, M., Russo, C., Ortíz, C., Bonaccorsi‐Riani, E., Brander, C., Bauer, T., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008793 · Cited by 91
Self-citationBuchmann, P., Dembek, C. J., Kuklick, L., Jäger, C., Tedjokusumo, R., von Freyend, M. J., Drebber, U., Janowicz, Z. A., Melber, K., & Protzer, U. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.074 · Cited by 88
Self-citationWilson, G. K., Brimacombe, C. L., Rowe, I. A. C., Reynolds, G. M., Fletcher, N. F., Stamataki, Z., Bhogal, R. H., Simões, M. L., Ashcroft, M. A., Afford, S. C., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.018 · Cited by 81
Self-citationMechanisms of HCV-induced liver cancer: What did we learn from in vitro and animal studies?
Rusyn, I., & Lemon, S. M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.028 · Cited by 78
Ariumi, Y., Kuroki, M., Dansako, H., Abe, K.-I., Ikeda, M., Wakita, T., & Kato, N. (2008) · Journal of Virology · doi:10.1128/jvi.00351-08 · Cited by 75
Evaluation of Abdominal Ultrasonography Mass Screening for Hepatocellular Carcinoma in Taiwan
Yeh, Y., Hu, T., Cho, P.-Y., Chen, H.-H., Yen, A. M.-F., Chen, S. L., Chiu, S. Y., Fann, J. C., Su, W., Fang, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26703 · Cited by 75
Hepatitis D and hepatocellular carcinoma
Abbas, Z. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i5.777 · Cited by 67
Immune Control of Hepatitis B Virus
Bauer, T., Sprinzl, M. F., & Protzer, U. (2011) · Digestive Diseases · doi:10.1159/000329809 · Cited by 63
Self-citationHara, Y., Yanatori, I., Ikeda, M., Kiyokage, E., Nishina, S., Tomiyama, Y., Toida, K., Kishi, F., Kato, N., Imamura, M., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.07.024 · Cited by 62
Sunami, Y., Ringelhan, M., Kókai, E., Lu, M., O’Connor, T., Lorentzen, A., Weber, A., Rodewald, A., Müllhaupt, B., Terracciano, L., et al. (2016) · Hepatology · doi:10.1002/hep.28435 · Cited by 62
Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication
Farquhar, M. J., Humphreys, I., Rudge, S. A., Wilson, G. K., Bhattacharya, B., Ciaccia, M., Hu, K., Zhang, Q., Mailly, L., Reynolds, G. M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.009 · Cited by 62
Self-citationMicroRNAs in hepatic pathophysiology
Murakami, Y., & Kawada, N. (2016) · Hepatology Research · doi:10.1111/hepr.12730 · Cited by 59
Wijetunga, N. A., Pascual, M., Tozour, J. N., Delahaye, F., Alani, M. T., Adeyeye, M., Wolkoff, A. W., Verma, A. K., & Greally, J. M. (2016) · Oncogene · doi:10.1038/onc.2016.340 · Cited by 58
Long, X. D., Ma, Y., Qu, D. Y., Liu, Y. G., Huang, Z. Q., Huang, Y. Z., Lin, Z., Wei, N., & Zhou, S. C. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.03.003 · Cited by 57
Selitsky, S. R., Dinh, T. A., Toth, C. L., Kurtz, C. L., Honda, M., Struck, B. R., Kaneko, S., Vickers, K. C., Lemon, S. M., & Sethupathy, P. (2015) · mBio · doi:10.1128/mbio.01500-15 · Cited by 57
Gu, X., Qi, P., Zhou, F., Ji, Q., Wang, H., Dou, T., Zhao, Y., & Gao, C. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.09.353 · Cited by 56
Harouaka, D., Engle, R. E., Wollenberg, K. R., Diaz, G., Tice, A. B., Zamboni, F., Govindarajan, S., Alter, H. J., Kleiner, D. E., & Farci, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516879113 · Cited by 54
Han, K., Kim, D. Y., Park, J. Y., et al. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182755c13 · Cited by 42
Spaniel, C., Honda, M., Selitsky, S. R., Yamane, D., Shimakami, T., Kaneko, S., Lanford, R. E., & Lemon, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076867 · Cited by 40
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
Burza, M. A., Motta, B. M., Mancina, R. M., Pingitore, P., Pirazzi, C., Lepore, S. M., Spagnuolo, R., Doldo, P., Russo, C., Lazzaro, V., et al. (2015) · Hepatology · doi:10.1002/hep.28322 · Cited by 37
Hedegaard, D. L., Tully, D. C., Rowe, I. A. C., Reynolds, G. M., Bean, D. J., Hu, K., Davis, C., Wilhelm, A., Ogilvie, C. B., Power, K. A., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.048 · Cited by 29
Self-citationXu, H. F., Li, G., Yue, Z., & Li, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5159 · Cited by 27
Bernsmeier, C., Calabrese, D., Heim, M. H., & Duong, F. H. T. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12208 · Cited by 26
Hoh, A., Heeg, M., Ni, Y., Schuch, A., Binder, B., Hennecke, N., Blum, H. E., Nassal, M., Protzer, U., Hofmann, M., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00605-15 · Cited by 25
Self-citationRole of toll‐like receptor impairment in cirrhosis infection risk: are we making progress?
Pimentel‐Nunes, P., Roncon‐Albuquerque, R., Dinis-Ribeiro, M. J., & Leite-Moreira, A. F. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02334.x · Cited by 10
Cited by
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
D'souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5759 · Cited by 257
Metadata
- Authors
- Ringehan, M., McKeating, J. A., & Protzer, U.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2017-09-11
- Volume
- 372
- Issue
- 1732
- Pages
- 20160274
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2755250741
- Cited by
- 410
- References
- 134
- FWCI
- 21.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.